|
|
HHS General Counsel Mike Stuart Posts On X "Based on a review of the applicable facts, earlier today @HHSOGC referred Hims & Hers Health, Inc. ("Hims") to the Department of Justice for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions."
|
|
|
|
What's Going On With Novo Nordisk Stock On Friday?
|
|
|
|
Molina Healthcare, Coty, Illumina, Amazon And Other Big Stocks Moving Lower In Friday's Pre-Market Session
|
|
|
|
US FDA Chief Makary Warns FDA Will Take Swift Action Against Companies Mass-Marketing Illegal Copycat Drugs, Cannot Verify Safety, Quality Or Effectiveness Of Non-Approved Products
|
|
|
|
Hims & Hers Launches Compounded Version Of Wegovy, Novo Nordisk Threatens Legal Action
|
|
|
|
Google's Jaw-Dropping Capex – AI Story Has More Gas; Unstable Market Structures Hit Silver, Gold, Bitcoin, And Stocks
|
|
|
|
Novo Nordisk Decides To Take Legal Action Against Hims & Hers' Illegal Mass Compounding Of Semaglutide Pill
|
|
|
|
Hims & Hers Stock Jumps On Compounded Wegovy Launch
|
|
|
|
Novo Nordisk CEO Says People Taking Hims Compounded Pill Will Be 'Wasting $49' Because The Compound Will Not Be Absorbed
|
|
|
|
Hims & Hers Health shares are trading higher after the company announced an expansion of its weight loss specialty by enabling providers to prescribe a Compounded Semaglutide Pill.
|
|